US Stock MarketDetailed Quotes
ATHA Athira
- 3.110
- -0.100-3.12%
Close Jul 19 16:00 ET
- 3.140
- +0.030+0.96%
Post 18:55 ET
119.20MMarket Cap-1019P/E (TTM)
3.240High3.070Low59.87KVolume3.210Open3.210Pre Close186.85KTurnover0.22%Turnover RatioLossP/E (Static)38.33MShares4.29852wk High1.12P/B83.67MFloat Cap1.33052wk Low--Dividend TTM26.90MShs Float34.790Historical High--Div YieldTTM5.30%Amplitude1.330Historical Low3.120Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Athira Stock Forum
$Athira(ATHA.US)$
Athira Pharma Completes First Cohort in Phase 1 Clinical Trial of ATH-1105, an Oral, Small Molecule Drug Candidate for Amyotrophic Lateral Sclerosis (ALS)
Athira Pharma To Be Issued US Patent For "Methods Of Treating Parkinson's Disease And Lewy Body Disease
NEWS
Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease
Athira Pharma, Inc. announces promising preclinical data on fosgonimeton for Alzheimer's disease treatment. Fosgonimeton shows neuroprotective effects, counteracts Aβ-induced toxicity, and enhances neuronal health. Key findings include improved neuronal survival, reduced tau hyperphosphorylation, enhanced activation of pro-survival effectors, and cog...
Benzinga· 2 mins ago
In reaction to earnings/guidance:
• $United Microelectronics(UMC.US)$ +0.8% (August revs)
Other news:
• $ChannelAdvisor(ECOM.US)$ +54.4% (to be acquired for $23.10 per share)
• $IVERIC bio(ISEE.US)$ +42.3% (topline data from Zimura GATHER2 phase 3 clinical trialingeographic atrophy)
• $Monte Rosa Therapeutics(GLUE.US)$ +10% (receives FDA clearance of Investigational New Drug Application for MRT-2359)
• $IDEAYA Biosciences(IDYA.US)$ +4.9% (re...
• $Funko(FNKO.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $28 (from $25)
• $Southwest Airlines(LUV.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $55 (from $57)
• $MetLife(MET.US)$ : Wolfe Research Upgrades to Outperform from Peerperform
• $MGIC Investment(MTG.US)$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $16 (from $15)
• $Snowflake(SNOW.US)$ : JPMorgan Upgrades to Overweigh...
hi
No comment yet